Mechanism of monoamine oxidase‐A inhibition by BW 1370U87

Drug Development Research

Volumn 25, Issue 3, 1992, Pages 191-199

  White, Helen L ^a   Scates, Philip W ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

antidepressant; competitive inhibition; dialysis; enzyme kinetics; serotonin; tyramine

Indexed keywords

1 ETHYLPHENOXATHIIN 10,10 DIOXIDE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; MONOAMINE OXIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; DIALYSIS; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; LIVER; NONHUMAN; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

EID: 0026582778     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.430250303     Document Type: Article

References (25)

1. CDNA cloning of human liver monoamine oxidase A and B: molecular differences between two forms of the enzyme. Proc. Natl
2. Oral tyramine pressor test and the safety of monoamine oxidase inhibitor drugs: Comparison of brofaromine and tranylcypromine in healthy subjects
3. Tyramine potentiation during treatment with MAO inhibitors: brofaromine and moclobemide vs. irreversible inhibitors
4. Monoamine oxidase inhibition by phenelzine and brofaromine in healthy volunteers
5. A comparison of the pharmacological and biochemical properties of substrate‐selective monoamine oxidase inhibitors
6. Moclobemide, an antidepressant with short‐lasting MAO‐A inhibition: brain catecholamines and tyramine pressor effects in rats
7. Neurochemical profile of moclobemide, a short‐acting and reversible inhibitor of monoamine oxidase type A
8. An update on the identity crisis of monoamine oxidase: new and old evidence for the independence of MAO‐A and B
9. The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine
10. Effect of moclobemide, a new reversible monoamine oxidase inhibitor, on absorption and pressor effect of tyramine
11. Moclobemide, a new reversible MAO inhibitor‐interaction with tyramine and tricyclic antidepressants in healthy volunteers and depressive patients
12. Expression of functional human monoamine oxidase A and B cDNAs in mammalian cells
13. Comparative behavioral effects of clorgyline and pargyline in man: a preliminary evaluation
14. Selective inhibition of monoamine oxidase type A: clinical and antidepressant effects and metabolic changes in man
15. Differential response patterns to MAO inhibitors and tricyclics
16. Some pharmacological and clinical aspects of reversible MAO inhibitors
17. The monoamine oxidase inhibiting properties of CGP 11305A
18. A comparative trial of a new monoamine oxidase inhibitor in depression
19. Multiple binding sites of human brain and liver monoamine oxidase: substrate specifities, selective inhibitions, and attempts to separate enzyme forms
20. 2 on monoamine oxidases A and B of human brain and liver
21. Characterization of multiple substrate binding sites of MAO
22. A clinical overview of monoamine oxidase inhibitors